Induction immunotherapy in pediatric heart transplant recipients: A multicenter study

Journal of Heart and Lung Transplantation

Volumn 18, Issue 5, 1999, Pages 460-469

  Boucek Jr , Robert J ^a   Naftel, David ^b   Boucek, Mark M ^c   Chinnock, Richard ^d   Morrow, Robert W ^e   Pahl, Elfriede ^f   Disano, Sharon ^g  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c CHILDREN S HOSPITAL   (United States)

^d LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^f CHILDREN'S MEMORIAL HOSPITAL   (United States)

^g JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; OKT 3; THYMOCYTE ANTIBODY;

ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; ECHOCARDIOGRAPHY; GRAFT REJECTION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; SURVIVAL;

ADOLESCENT; CHILD; FOLLOW-UP STUDIES; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; MUROMONAB-CD3; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0344223376     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(98)00076-X     Document Type: Article

References (18)

1. Bailey L.L., Concepcion W., Shattuck H., et al. Method of heart transplantation for treatment of hypoplastic left heart syndrome. J Thorac Cardiovasc Surg. 92:(1):1986;1-5.
2. Boucek M.M., Hodgkins D.D., Mathis C.M., Kanakriyeh M.S., Boucek R.J. Jr, Gundry S.R., Bailey L.L. Accuracy of echocardiographic rejection surveillance in infant cardiac transplantation. J Heart Transplant. 9:1990;63.
3. Myles J.L., Ratliff N.B., McMahon J.T., et al. Reversibility of myocyte injury in moderate and severe acute rejection in cyclosporine-treated cardiac transplant patients. Arch Pathol Lab Med. 111:1987;947-952.
4. Fricker F.J., Griffith I.I., Hardesty R.L., et al. Experience with heart transplantation in children. Pediatrics. 79:1987;138-146.
5. Bonnefoy-Bernard N., Revillard J.P. Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3. J Heart Lung Transplant. 15:1996;435-442.
6. Frist W.H., Merrill W.H., Eastburn T.E., Atkinson J.B., Stewart J.R., Hammon J.W., Bender H.W. Unique antithymocyte serum versus induction immunotherapy after heart transplantation. J Heart Transplant. 9:1990;489-494.
7. Carey J., Frist W.H. Use of polyclonal antilymphocytic preparations for prophylaxis in heart transplantation. J Heart Transplant. 9:1990;297-300.
8. Boucek M.M., Mathis C.M., Chinnock R.E., Kanakriyeh M.S., Nehlsen-Cannarella S., Gundry S.R., Bailey L.L., Boucek R.J. Jr. Polyclonal versus monoclonal anti-T cell antibody therapy in infant heart transplantation. J Heart Transplant. 10:1991;161.
9. Boucek M.M., Mathis C.M., Labeck L.K., Nehlsen-Cannarella S., Gundry S., Bailey L. Prophylactic anti-thymocyte serum reduces rejection frequency after pediatric heart transplantation. J Heart Lung Transplant. 11:1992;205.
10. Boucek M.M., Mathis C.M., Gundry S.R., Bailey L. Antithymocyte serum prophylaxis enduring reduction of rejection episodes in pediatric heart transplantation . J Heart Lung Transplant. 13:1994;S35.
11. Boucek RJ Jr, Naftel D MD, Boucek MM, Chinnock R, Morrow RW, Pahl E, DiSano S. Induction immunotherapy in pediatric heart transplant recipients: a multi-institutional evaluation. J Heart Lung Trans 1998;16:24.
12. Shaddy R.A., Bullock E.A., Morwessel N.J., Hannon D.W., et al. Murine monoclonal CD3 antibody (OKT3)-based early rejection prophylaxis in pediatric heart transplantation. J Heart Lung Transplant. 12:1993;434-439.
13. Billingham R.E., Brent L., Medawar P.B. Actively acquired tolerance of foreign cells. Nature. 172:1953;603-606.
14. Ridge J.P., Fuchs E.J., Matzinger P. Neonatal tolerance revisted turning on newborn T cells with dendritic cells . Science. 217:1996;1723-1729.
15. Rotando K., Naftel D., Boucek R.J. Jr, et al. Allograft rejection following cardiac transplantation in infants and children a multi-institutional study . J Heart Lung Transplant. 15:1996;S80.
16. Muller T.F., Grebe S.O., Neuman C., Heymanns J., Radsak L., Sprebger H., Lange H. Persistent long-term changes in lymphocyte subsets induced by polyclonal antibodies. Transplantation. 64:(10):1997;1432-1437.
17. Frank R.A., Sanchez J.A., Addonizio L.J., Hsu D.T., Rose E.A., Micher R.E. OKT3 induction therapy increases early infections and does not reduce early rejections in pediatric heart transplantation. J Heart Lung Transplant. 10:1991;161.
18. Carrier M., Jenicek M., Pelletier. Value of monoclonal antibody OKT3 in solid organ transplantation a meta-analysis . Transplantation Proc. 24:1992;2586-2591.